NTLA News and Press, Intellia Therapeutics Inc.

2024-07-13 10:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-09 07:59:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips CRISPR technology, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing tool that allows scientists to make precise modifications to the DNA of living o...

2024-07-09 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artificial intelligence stocks will be the choice of growth-oriented investors for years to come. But if you’re a buy-and-hold investor with above-average patience, this is a time to...

2024-07-09 05:56:00 ET Intellia Therapeutics (NASDAQ: NTLA) just published some new data that suggests the company has what it takes to continue being a leader in the gene editing space. While there's still a lot of work to be done to confirm Intellia's new finding and make money fr...

2024-07-08 18:11:27 ET More on Intellia Therapeutics Intellia Therapeutics Presents Promising In Vivo CRISPR Results Intellia Therapeutics: 3 Near-Term Pivotal In Vivo Gene Therapies Intellia Therapeutics, Inc. (NTLA) Q1 2024 Earnings Call Transcript Intellia...

2024-07-05 14:14:56 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech can be pretty unpredictable. Biotech stocks are highly volatile, and picking carefully can be the difference between losing all your capital and making unimaginable pro...

2024-07-03 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-02 08:30:00 ET It was a rough first half of the year for Cathie Wood. The co-founder, CEO, and investor at Ark Invest saw her family of aggressive growth exchange-traded funds lose badly to the market. But she's not throwing in the towel. Wood publishes Ark's daily transactions,...

2024-07-01 14:34:13 ET Summary Beam Therapeutics Inc. is a gene editing company focused on precision genetic medicines through base editing. The company has notable collaborations with Pfizer and other pharma concerns, with several pipeline milestones in 2024. The company is m...

2024-06-28 10:28:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Searching for quality undiscovered biotech stocks can be a bit like a treasure hunt. The biotech scene is full of intriguing innovators trying to progress their treatments through various c...